Home > Boards > US Listed > Biotechs > Marker Therapeutics Inc (MRKR)

re:"$TPIV 80 person study will be to compare

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
apostrophe Member Profile
 
Followed By 19
Posts 1,084
Boards Moderated 0
Alias Born 10/17/06
160x600 placeholder
Marker Therapeutics Shares Rise Premarket on Key FDA Designation Dow Jones News - 1/20/2022 6:51:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/20/2022 6:00:59 AM
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Pancreatic Cancer GlobeNewswire Inc. - 1/19/2022 4:49:54 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/9/2021 5:19:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2021 8:02:26 AM
Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors PR Newswire (US) - 12/9/2021 7:00:00 AM
Marker Therapeutics Announces that Data from Investigator-Sponsored Phase 1 Study With its MultiTAA-Specific T Cells to be Presented at the 2021 American Society of Hematology Annual Meeting PR Newswire (US) - 11/18/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 7:11:46 AM
Marker Therapeutics EPS misses by $0.02 Seeking Alpha - 11/10/2021 4:38:10 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2021 4:11:12 PM
Marker Therapeutics Reports Third Quarter 2021 Operating and Financial Results PR Newswire (US) - 11/10/2021 4:05:00 PM
Marker Therapeutics to Present at Three Upcoming September Investor Conferences PR Newswire (US) - 9/7/2021 4:05:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/20/2021 6:03:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/19/2021 4:13:47 PM
Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas PR Newswire (US) - 8/19/2021 4:05:00 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/10/2021 5:11:55 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2021 4:03:08 PM
Marker Therapeutics Reports Second Quarter 2021 Operating and Financial Results PR Newswire (US) - 8/10/2021 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2021 4:36:58 PM
Marker Therapeutics opens new cGMP manufacturing facility in Houston Seeking Alpha - 7/28/2021 4:13:52 PM
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility PR Newswire (US) - 7/28/2021 4:05:00 PM
Marker Therapeutics completes safety lead-in portion of mid-stage leukemia study Seeking Alpha - 7/6/2021 7:50:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 7:24:18 AM
Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML PR Newswire (US) - 7/6/2021 7:00:00 AM
Marker Therapeutics to Present at the Virtual Raymond James Human Health Innovation Conference PR Newswire (US) - 6/16/2021 4:05:00 PM
apostrophe   Tuesday, 04/19/16 04:19:15 PM
Re: lasers post# 15431
Post # of 31708 
re:"$TPIV 80 person study will be to compare TPIV200 vs Chemotherapy Drug: Cyclophosphamide "

cyclophosphamide, Cytoxan (cont.)

SIDE EFFECTS: Side effects of cyclophosphamide include:
hair loss, vomiting, diarrhea, mouth sores, weight loss, sterility, and jaundice.

Cyclophosphamide causes kidney failure, and it also may affect the heart and lungs. Cyclophosphamide suppresses production of blood cells from the bone marrow, including white blood cells (leukopenia), red blood cells (anemia) and platelets (thrombocytopenia). Leukopenia reduces the ability of the body to fight infection, thrombocytopenia impairs the ability of blood to clot, and anemia reduces the ability of blood to carry oxygen. Cyclophosphamide suppresses the immune system which may result in serious and sometimes fatal infections. Severe allergic reactions also may occur. Cyclophosphamide may cause inflammation of the urinary bladder with bleeding (hemorrhagic cystitis). This can result in lower abdominal pain from the bladder, problems urinating due to blood clots, and anemia due to loss of blood. "

http://www.medicinenet.com/cyclophosphamide/page2.htm

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences